Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for ADHD and Comorbid Trichotillomania
NCT00552266Phase 4Unknown
- Sponsor
- Geha Mental Health Center
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) and trichotillomania (TTM), sponsored by Geha Mental Health Center. Primary endpoint: Massachusetts General Hospital Hair Pulling Scale at 12 weeks. Status: unknown.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)trichotillomania (TTM)
Beyond the preview
Go deeper on NCT00552266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00552266.